Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001213900-26-043795
Filing Date
2026-04-15
Accepted
2026-04-15 08:31:20
Documents
3

Document Format Files

Seq Description Document Type Size
1 PROSPECTUS SUPPLEMENT ea028633402-424b3_kazia.htm 424B3 116659
2 GRAPHIC ea028633402_img1.jpg GRAPHIC 3154
3 GRAPHIC ea028633402_ex10-1img1.jpg GRAPHIC 13025
  Complete submission text file 0001213900-26-043795.txt   140542
Mailing Address THREE INTERNATIONAL TOWERS LEVEL 24, 300 BARANGAROO AVENUE SYDNEY NSW Australia 2000
Business Address THREE INTERNATIONAL TOWERS LEVEL 24, 300 BARANGAROO AVENUE SYDNEY NSW Australia 2000 01161298780088
KAZIA THERAPEUTICS LTD (Filer) CIK: 0001075880 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 424B3 | Act: 33 | File No.: 333-284606 | Film No.: 26862613
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)